Pharmafile Logo
Pharmafocus logo
Advanced Search
ususnsu

Majority of British people worried about the fate of the NHS in post-Brexit US trade deal, survey reveals

November 28, 2019
Medical Communications Boris Johnson, Jeremy Corbyn, NHS, Trump, brexit, european union

In a newly released survey on “Over-The-Counter (OTC) and Pharma 2019”, by the business data platform Statista, 55% of people …

News
34778112_496a002303_b

Drugmakers cut prices by 61% to get on Chinese reimbursement list

November 28, 2019
Manufacturing and Production AstraZeneca, China, China National Reimbursement Scheme, Novartis, Roche Holding

AstraZeneca and Roche Holding are among a number of drugmakers to cut their prices in order to get on China’s …

News
pfizer_building_logo1_19

Pfizer’s Ibrance approved by NICE, to be added to the Cancer Drugs Fund

November 28, 2019
Manufacturing and Production, Research and Development Cancer Drugs Fund, NHS, NICE, Pfizer, breast cancer, ibrance, pharma

Today it was announced that the National Institute for Health and Care Excellence (NICE) has recommended Pfizer’s Ibrance (palbociclib) to …

News

US prosecutors open criminal probe of six drugs companies in opioid investigation

November 28, 2019
Business Services, Manufacturing and Production Federal Substance Act, Opiod, Trump, Trump Opiod, opiod crisis

Federal Prosecutors from the US Attorney’s Office in the Eastern District of New York have subpoenaed five opioid manufactures. The …

News
corbyn_nhs

Corbyn reveals documents showing US-UK meetings on deregulating NHS drug pricing

November 27, 2019
Research and Development, Sales and Marketing Jeremy Corbyn, Labour Party, NHS, US, pharma

Labour Leader Jeremy Corbyn has showed off documents that detail secret trade meetings between the US and UK Governments, where …

News
immagine-1

Organisation of Islamic Cooperation sets up new halal pharmaceuticals technical committee

November 27, 2019
Research and Development Arabic, Halal, Organisation of Islamic Cooperation, Saudi Arabia, malaysia

The Organisation of Islamic Cooperation’s (OIC) standards body, the Standards and Metrology Institute for Islamic Countries (SMIIC), has set up …

News
shutterstock_79370437

New ICER report reveals most cost-effective rheumatoid arthritis therapies

November 27, 2019
Research and Development, Sales and Marketing AbbVie, Eli Lilly, Humira, Olumiant, Pfizer, Rinvoq, Xeljanz, pharma

The Institute for Clinical and Economic Review (ICER) has unveiled a new report comparing the clinical efficacy and cost-effectiveness of …

News
images

NICE rejects Keytruda for routine use in NHS bladder cancer treatment

November 27, 2019
Research and Development Cancer Drugs Fund, bladder cancer, cancer research

The National Institute for Health and Care Excellence (NICE) has given an initial ‘no’ for Keytruda’s (pembrolizumab) use in treating …

News
astrazeneca_plaque

AstraZeneca and Novoheart team up to develop human ‘heart-in-a-jar’

November 27, 2019
Research and Development Heart in a Jar, Novoheart, heart disease

AstraZeneca and Novoheart are collaborating on developing a functioning miniature human heart model of heart failure, a first of its …

News
1911-sickle-cells

FDA approves GBT’s Oxbryta to treat sickle cell disease

November 26, 2019
Manufacturing and Production FDA, FDA Trump, Oxbryta, Sickle cell, sickle cell disease

The FDA announced yesterday that it has approved Global Blood Therapeutics’ marketing application for its haemoglobin polymerisation inhibitor Oxbryta, which …

News
shutterstock_2

Singapore and South Korea agree to cooperate on Good Manufacturing Practice

November 26, 2019
Manufacturing and Production ASEAN, GMP, North Korea, ROK, Singapore, south korea

At a joint summit on Saturday, South Korea’s Ministry of Food and Drug Safety signed a memorandum of understanding (MOU) …

News
5369645453_2a0fbd2a9d_b

US lawmakers call for FDA office in Israel

November 26, 2019
Manufacturing and Production FDA, Golan Heights, Israel FDA, Netanyahu, Trump, USA, congress, israel

A bipartisan group of 21 US members of Congress has called for the establishment of an FDA office in Israel, …

News
celltrion1

Europe approves first subcutaneous version of biosimilar infliximab

November 26, 2019
Manufacturing and Production, Sales and Marketing arthritis, biosimilars, celltrion, infliximab, pharma

The European Commission has chosen to authorise Celltrion Healthcare’s Remsima SC, a biosimilar of infliximab and the first subcutaneous formulation …

News
30562517863_f4ff8e801a_b

Conservatives pledge to invest in preventing and curing disease in election manifesto

November 26, 2019
Manufacturing and Production Boris Johnson, Conservative Party, Election 2019, Tories NHS, Tory Manifesto

Prime Minister Boris Johnson launched the Conservative Party’s manifesto on Sunday, promising to invest more into research to prevent and …

News

The coming age of biosimilars

November 25, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, feature, pharma

With more and more biosimilars securing approval and the sheer potential value they have to offer for healthcare systems around …

Feature
m-mansuri_370x250px

Sanofi’s head of strategy and business development to retire amid company review

November 25, 2019
Sales and Marketing Bristol Meyers, Gilead, Sanofi, Shell

One of Sanofi’s most senior strategy bosses is set to retire at the end of the month. Muzammil Mansuri, Executive …

News

FDA approves AstraZeneca’s Calquence in chronic lymphoma

November 25, 2019
Sales and Marketing Astrazenaca, Calquence, FDA, Health Canada, leukaemia, oncology

The FDA has approved AstraZeneca’s BTK inhibitor Calquence (acalabrutinib) in the treatment of chronic lymphocytic leukaemia (CLL) and small lymphocytic …

News
fdaoutsideweb

FDA fast-tracks psilocybin treatment for major depressive disorder

November 25, 2019
Sales and Marketing Controlled Substance Act, FDA, breakthrough therapy, major depressive disorder, psilocybin

The FDA has granted a Breakthrough Therapy designation to the Usona Institute for its trial use of psilocybin in the …

News
novartis_outside_1

Novartis acquires The Medicines Company in a deal worth $9.7 billion

November 25, 2019
Sales and Marketing Novartis, The Medicines Company, pharma

Novartis agreed a $9.7 billion deal to acquire the US-based The Medicines Company, it announced Sunday. The transaction was unanimously …

News
roche__tree

Roche’s Tecentriq combo outclasses Nexavar in unresectable hepatocellular carcinoma

November 25, 2019
Research and Development, Sales and Marketing Cancer, Roche, immunotherapy, pharma, tecentriq

Roche has revealed new Phase 3 data for its immunotherapy drug Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) in the …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026